FMP

FMP

Enter

SMMT - Summit Therapeutics ...

Financial Summary of Summit Therapeutics Inc.(SMMT), Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medic

photo-url-https://financialmodelingprep.com/image-stock/SMMT.png

Summit Therapeutics Inc.

SMMT

NASDAQ

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.

3.59 USD

-0.14 (-3.9%)

About

ceo

Mr. Robert W. Duggan

sector

Healthcare

industry

Biotechnology

website

https://www.summittxinc.com

exchange

NASDAQ

Description

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cam...

CIK

0001599298

ISIN

US86627T1088

CUSIP

86627T108

Address

One Broadway

Phone

617 514 7149

Country

US

Employee

105

IPO Date

Mar 5, 2015

Summary

CIK

0001599298

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

86627T108

ISIN

US86627T1088

Country

US

Price

3.59

Beta

-1.2

Volume Avg.

2.23M

Market Cap

2.52B

Shares

-

52-Week

1.3-5.22

DCF

-0.07

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-3.63

P/B

-

Website

https://www.summittxinc.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest SMMT News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep